Last reviewed · How we verify
NCT03286985: preTIME
The Prevalence and Incidence of DVT in General ICU
trial in Deep Venous Thrombosis in 200 participants. Completed in 31 December 2017.
31 December 2017
Quick facts
| Lead sponsor | Masaryk Hospital Krajská zdravotní a.s. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 September 2017 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2017 |
| Sites | 1 location across Czechia |
Conditions studied
- Deep Venous Thrombosis — all drugs for Deep Venous Thrombosis →
Sponsor
Masaryk Hospital Krajská zdravotní a.s.
Who can join
Eligibility, any sex, with Deep Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Deep venous thrombosis (DVT) represents a major problem in intensive care unit (ICU) patients. Despite the use of recommended pharmacological prophylaxis with low molecular weight heparin (LMWH), the incidence of DVT during ICU stay has been reported between 5 and 15 %. The incidence may vary due to many factors, for example the type of ICU population, the type of protocol of pharmacological prophylaxis and also the type of diagnostic approach. Before formerly planned clinical study targeted to lower DVT incidence by individualizing the dose of LMWH, the investigators decided to evaluate the real DVT incidence in the investigated ICU. The prevalence and incidence will be assessed by ultrasound testing in general ICU patients. on the sample of 200 patients. The investigators hypothesize DVT incidence of 5 %. The compliance to the local DVT prophylaxis protocol will be also evaluated.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Fixed-dose enoxaparin provides efficient DVT prophylaxis in mixed ICU patients despite low anti-Xa levels: A prospective observational cohort study.
Benes J, Skulec R, Jobanek J, Cerny V. · · 2022 · cited 4× · PMID 34042098 · DOI 10.5507/bp.2021.031
Verify or expand the search:
- PubMed search for NCT03286985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deep Venous Thrombosis
Currently open trials in the same condition.
- NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT06913595 — Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery · Phase 1 · active not recruiting
- NCT05701917 — DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis · NA · recruiting
- NCT04924322 — Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies · Phase 2, PHASE3 · recruiting
Other Masaryk Hospital Krajská zdravotní a.s. trials
Trials by the same sponsor.
- NCT03924583 — Duplex Ultrasonography Performed by Nurses · unknown
- NCT03634215 — Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma · completed
- NCT04529187 — Effect of Midazolam and Dexmedetomidine on Heart Function - A Randomized MRI-based Study. · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03286985 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Masaryk Hospital Krajská zdravotní a.s.
- Last refreshed: 19 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03286985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing